News & Events

HTG Introduces the HTG EdgeSeq Pan B-Cell Lymphoma Panel

Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. , June 18, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch

full press release

Posted on:

Return To List

Page last updated